Jury May Decide Risperdal Time Bar
Two cases in front of the Pennsylvania Supreme Court could result in 40% of the over 7,000 Risperdal cases being time barred from moving forward. The Pennsylvania docket for Risperdal cases has grown significantly in the last few years. The Pennsylvania Supreme Court is being asked to reconsider two lower court rulings that began the […]
Conflicts of Interest in Medical Research
In Stephen Sheller’s book Lawyering In Times of Saints and Evil Doers (2015), Sheller tells the story of science for sale, the widespread conflict of interest created when doctors and researchers are influenced by payments they receive from pharmaceutical companies. In 2008, a Congressional inquiry led by Senator Charles E. Grassley (R-IA) exposed the extensive conflict of interest […]
PA Supreme Court Will Hear Appeal of Risperdal Time-Bar
The PA Supreme Court has agreed to review a Superior Court decision which would dismiss thousands of Risperdal cases due to statute of limitations. The two cases on appeal, Saksek v. Janssen and Winter v. Janssen, were dismissed for failing to bring a claim with in the applicable two year statue of limitations. The Supreme Court’s decision would […]
$4.7B Talc-Ovarian Cancer Verdict Against J&J
Juries across the country have been handing down “eye catching” verdicts for plaintiffs with ovarian cancer and their families against Johnson & Johnson. The most recent included a nearly $4.7 billion verdict for 22 plaintiffs in Missouri. Plaintiff’s claim J&J knowingly, for 49 years, sold talcum baby powder tainted with asbestos which resulted in the […]
Judge Urges Appeals Court to Uphold $70M Risperdal Verdict
Philadelphia Court of Common Pleas Judge Paula Patrick urges the Pennsylvania Superior Court to uphold the $70 Million jury verdict in A.Y. v. Janssen Pharmaceuticals. AY is one of many boys who developed gynecomastia after taking Janssen’s anti-psychotic medication Risperdal. This is the 5th trial for Risperdal, with over 6,000 awaiting trial in a consolidated […]
More Lawsuits Against Opioid Makers, Feds Assist Cities/States
More than 100 states, cities, counties and other public entities have filed opioid-related lawsuits against the drug manufacturers in 2017. The lawsuits being filed continue into 2018 including the city of Philadelphia who has enlisted Sheller PC and other high profile plaintiff’s firms to assist the city in the lawsuit. The suit included drug manufactures […]
Sheller Joins Phila. in Suit Against Opioid Manufacturers
Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid crisis. Five pharmaceutical companies are named in the suit: Allergan, Janssen (a subsidiary of Johnson & Johnson and manufacturer of Risperdal), Endo, Cephalon, and […]
Superior Court Allows Punitive Damages in Risperdal Mass Torts
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling prohibited punitive damages. Boys and young men who developed gynecomastia, female-like breasts, from taking the antipsychotic drug and whose cases had already […]
Plaintiff wins Bellwether Xarelto Case in Philadelphia Court
A Philadelphia jury awarded Lynn Hartman $27.8 million after finding drug manufacturers Johnson & Johnson and Bayer failed to warn about the dangers of their blood thinning drug Xarelto. The verdict includes $26 million in punitive damage, which juries award to plaintiffs when they believe the defendant acted egregiously. This bellwether case tried in Pennsylvania […]
Lone Risperdal Defense Verdict for J&J Overturned
